Physician profile
Helen H Koenigsman
NPI 1013179274
$2,089.65
in general payments reported to CMS, 2019-2025
13 companies · $654 in 2025
The $654 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58.19 · 2021: $62.51 · 2022: $397 · 2023: $458 · 2024: $460 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.74 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $703.88 | 2021-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Alcon Vision LLC | $407.88 | 2021-2025 | Hydrus Microstent, Clareon, Argos |
| Glaukos Corporation | $377.01 | 2022-2025 | Idosetr, Istent Infinite, Istent Trabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $159.55 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbvie INC. | $120.63 | 2023-2025 | |
| New World Medical,INC. | $92.06 | 2022-2023 | |
| Sight Sciences, INC. | $70.78 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Merz Pharmaceuticals, LLC | $40.09 | 2022 | |
| Optos, INC. | $35.32 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $28.02 | 2024 | |
| Allergan, INC. | $22.87 | 2020 | |
| Sun Pharmaceutical Industries INC. | $16.74 | 2024 | |
| Ivantis, INC | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Koenigsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.